MicroRNA Profiles in Triple Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Atara Ntekim
University of Ibadan
Principal Investigator - Olufunmilayo I. Olopade
University of Chicago
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Obafemi Awolowo University Teaching Hospital
Ile-Ife, Oshun, Nigeria
Akinwunmi Komolafe, MDOlukayode Arowolo, MDNot, yet, recruiting - University College Hospital
Ibadan, Oyo State, Nigeria
Adenike Adeniji-Sofoluwe, MDAtara Ntekim, MDAyorinde Folasire, MDRecruiting - Lagos State University Teaching Hospital
Lagos, Nigeria
Abiodun Popoola, MDAbiola Ibraheem, MDAyodele Sanni, MDNot, yet, recruiting - Lagos University Teaching Hospital
Lagos, Nigeria
Anthonia Sowunmi, MDFatima AbdulkareemThomas OlajideNot, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Nov 2021
- Primary completion
- 31 Mar 2027
- Completion
- 31 Aug 2030
- Last update posted
- 7 May 2026
- Registered enrollment
- 42
- Registry id
- NCT04771871
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.